Pulmonology professor Nikos Tsanakis: “We have three deaths of very young children. We sympathize with our parents. “
According to the professor, the prognosis for children in the coronavirus pandemic can hardly be called favorable. To date, 3 child deaths have been recorded, and a 15-year-old adolescent has been implanted with a defibrillator after coronavirus (implantation of defibrillators serves to prevent dangerous heart rhythm disturbances and can protect against sudden cardiac death. Ed.). In an interview with Mega, Nikos Tsanakis said:
“We have between 730,000 and 750,000 children between the ages of 12 and 18. We estimate that 25% will be exposed to the virus. If 1/4 is infected, you understand that we will have between 30,000 and 50,000 children with this disease. Therefore, we will have 300 to 500 children in hospitals. I don’t want to scare anyone, but parents should know these numbers. Children who have been vaccinated will not become seriously ill and most likely will not become infected. Children have better immune systems if they are vaccinated. The vaccine protects children, we do not know the side effects of the disease at an older age. The concept of herd immunity that we hoped for at the start of the pandemic may not exist, but mass vaccinations will reduce viral load. ”
The professor drew attention to the fact that vaccines with mRNA give much fewer side effects, almost zero. And even in the event of an allergic reaction, there is an effective instruction for its treatment. He expressed sympathy for the parents who have lost their children due to the coronavirus:
“We have three deaths among very young children, 30 deaths among people under 39 years of age. A 15-year-old child received a defibrillator after coronavirus. We sympathize with the parents. “
He also noted that vaccines for children under 12 are undergoing clinical trials.
As our publication reported, given the start of the school year and the opening of schools, the Greek Prime Minister approved vaccination of children over 12 years old, recommended by specialists. A decision was made to include private pediatricians in the vaccination process for children. A in Germany from mid-October the BioNTech vaccine will be available for vaccination in the 5-11 age group.